These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12193708)

  • 1. Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization.
    Klugewitz K; Blumenthal-Barby F; Schrage A; Knolle PA; Hamann A; Crispe IN
    J Immunol; 2002 Sep; 169(5):2407-13. PubMed ID: 12193708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
    Nakamura T; Kamogawa Y; Bottomly K; Flavell RA
    J Immunol; 1997 Feb; 158(3):1085-94. PubMed ID: 9013946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells.
    Oran AE; Robinson HL
    J Immunol; 2003 Aug; 171(4):1999-2005. PubMed ID: 12902504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble protein but not peptide administration diverts the immune response of a clonal CD4+ T cell population to the T helper 2 cell pathway.
    Degermann S; Pria E; Adorini L
    J Immunol; 1996 Oct; 157(8):3260-9. PubMed ID: 8871620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl6 is essential for the generation of long-term memory CD4+ T cells.
    Ichii H; Sakamoto A; Arima M; Hatano M; Kuroda Y; Tokuhisa T
    Int Immunol; 2007 Apr; 19(4):427-33. PubMed ID: 17307796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells.
    Wang X; Mosmann T
    J Exp Med; 2001 Oct; 194(8):1069-80. PubMed ID: 11602637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of B cells in the development of CD4 effector T cells during a polarized Th2 immune response.
    Liu Q; Liu Z; Rozo CT; Hamed HA; Alem F; Urban JF; Gause WC
    J Immunol; 2007 Sep; 179(6):3821-30. PubMed ID: 17785819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS; Yang X; Kelso A; Hayglass KT
    Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LFA-1 on CD4+ T cells is required for optimal antigen-dependent activation in vivo.
    Kandula S; Abraham C
    J Immunol; 2004 Oct; 173(7):4443-51. PubMed ID: 15383575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver.
    Watanabe T; Yoshida M; Shirai Y; Yamori M; Yagita H; Itoh T; Chiba T; Kita T; Wakatsuki Y
    J Immunol; 2002 Mar; 168(5):2188-99. PubMed ID: 11859105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.
    De Smedt T; Smith J; Baum P; Fanslow W; Butz E; Maliszewski C
    J Immunol; 2002 Jan; 168(2):661-70. PubMed ID: 11777959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen.
    Thorstenson KM; Khoruts A
    J Immunol; 2001 Jul; 167(1):188-95. PubMed ID: 11418648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells.
    Morgan R; Gao G; Pawling J; Dennis JW; Demetriou M; Li B
    J Immunol; 2004 Dec; 173(12):7200-8. PubMed ID: 15585841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differentiated state of intestinal lamina propria CD4+ T cells results in altered cytokine production, activation threshold, and costimulatory requirements.
    Hurst SD; Cooper CJ; Sitterding SM; Choi Jh; Jump RL; Levine AD; Barrett TA
    J Immunol; 1999 Dec; 163(11):5937-45. PubMed ID: 10570280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose IL-2 and IL-15 enhance the in vitro priming of naive CD4+ T cells for IFN-gamma but have differential effects on priming for IL-4.
    Seder RA
    J Immunol; 1996 Apr; 156(7):2413-22. PubMed ID: 8786299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-beta-producing cells in the absence of CD8 T cell activation.
    Foucras G; Coudert JD; Coureau C; Guéry JC
    J Immunol; 2000 Nov; 165(9):4994-5003. PubMed ID: 11046027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naive CD4+ T cells exhibit distinct expression patterns of cytokines and cell surface molecules on their primary responses to varying doses of antigen.
    Ise W; Totsuka M; Sogawa Y; Ametani A; Hachimura S; Sato T; Kumagai Y; Habu S; Kaminogawa S
    J Immunol; 2002 Apr; 168(7):3242-50. PubMed ID: 11907078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burn injury promotes antigen-driven Th2-type responses in vivo.
    Guo Z; Kavanagh E; Zang Y; Dolan SM; Kriynovich SJ; Mannick JA; Lederer JA
    J Immunol; 2003 Oct; 171(8):3983-90. PubMed ID: 14530317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.